Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atara Biotherapeutics Inc.

www.atarabio.com

Latest From Atara Biotherapeutics Inc.

Vical Faced With Failure of Another Vaccine Trial

Company will focus on getting oral anti-fungal candidate VL-2397 over the finish line, after another pipeline blow-up.

Research & Development Infectious Diseases

Pipeline Watch: Phase III Progress With Burosumab, Duvelisib And Galcanezumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Appointments: C4 Therapeutics, ORIC Pharma, CytRx, Audentes, Atara, Caribou, Sangamo And Pliant Announce Changes

New appointments announced over the past week include new CEOs at C4 Therapeutics and ORIC pharma, COO at CytRx, President at Audentes, global R&D head at Atara, CBO at Caribou, CTO at Sangamo, and chairman at Pliant.

 

Appointments Leadership

Appointments: Changes At Axovant Sciences, Immunocore, Sangamo Therapeutics, Circassia, MaxCyte and CANbridge Life Sciences

Pharma and biotech appointments this week include a management shake up at Axovant Sciences, a new CEO at Immunocore, Sangamo's latest legal hire, and new board members at Circassia and MaxCyte.
Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Atara Biotherapeutics Inc.
  • Senior Management
  • Isaac Ciechanover, MD, Pres. & CEO
    Utpal Koppikar, CFO
    Dietmar Berger, MD, PhD, Global Head, R&D
    Gad Soffer, EVP, Chief Strategy Officer
  • Contact Info
  • Atara Biotherapeutics Inc.
    Phone: (650) 278-8930
    611 Gateway Blvd.
    Ste. 900
    South San Francisco, CA 94080
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register